Security key
761330109
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 54,870,424
- Total 13F value
- $1,528,696,909
- Share change
- +764,017
- Put/Call ratio
- 229%
- SEC-reported price per share
- $27.86
- Number of holders
- 155
- Value change
- +$20,536,734
- Number of buys
- 69
- Number of sells
- 61
- Shares outstanding
- 104,661,494
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
155
Top holders
10
RVNC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Revance Therapeutics, Inc. SEC filings
Revance Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 761330109
Recent filing periods:
Ownership snapshot
Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 5.1%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
5.1%
JPMORGAN CHASE & CO
4.8%
VANGUARD GROUP INC
3.5%
Palo Alto Investors LP
3.1%
ALLIANCEBERNSTEIN L.P.
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
5.1%
|
$158,506,000
5,347,678 shares
|
— | 30 Jun 2021 |
| JPMORGAN CHASE & CO |
13F
Company
|
4.8%
|
$149,490,000
5,043,571 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
3.5%
|
$107,082,000
3,612,748 shares
|
— | 30 Jun 2021 |
| Palo Alto Investors LP |
13F
Company
|
3.1%
|
$94,903,000
3,201,866 shares
|
— | 30 Jun 2021 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
3%
|
$91,518,000
3,087,666 shares
|
— | 30 Jun 2021 |
| Capital World Investors |
13F
Company
|
2.8%
|
$87,942,000
2,967,000 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
155
Shares
54,870,424
Rows available
155
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q3 2021 holders
155
Holder diff
154
| Investor | Q3 2025 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend